메뉴 건너뛰기




Volumn 22, Issue 7, 2007, Pages 1806-1810

Anaemia of CKD - The CHOIR study revisited

Author keywords

Anemia; CKD; Epoetin; Haemoglobin; Kidney disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

EID: 34547613486     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm185     Document Type: Note
Times cited : (19)

References (16)
  • 1
    • 0032572913 scopus 로고    scopus 로고
    • The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    • Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339:584-590
    • (1998) N Engl J Med , vol.339 , pp. 584-590
    • Besarab, A.1    Bolton, W.K.2    Browne, J.K.3
  • 2
    • 33750983605 scopus 로고    scopus 로고
    • CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease
    • Singh AK, Szczech L, Tang KL et al. CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
    • (2006) N Engl J Med , vol.355 , pp. 2085-2098
    • Singh, A.K.1    Szczech, L.2    Tang, K.L.3
  • 3
    • 33751002326 scopus 로고    scopus 로고
    • CREATE Investigators. Normalization of hemoglobin level in. patients with chronic kidney disease and anemia
    • Drueke TB, Locatelli F, Clyne N et al. CREATE Investigators. Normalization of hemoglobin level in. patients with chronic kidney disease and anemia. N Engl J Med 2006; 355:2071-2084
    • (2006) N Engl J Med , vol.355 , pp. 2071-2084
    • Drueke, T.B.1    Locatelli, F.2    Clyne, N.3
  • 4
    • 33846682340 scopus 로고    scopus 로고
    • Understanding recent haemoglobin trials in CKD: Methods and lesson learned from CREATE and CHOIR
    • Levin A. Understanding recent haemoglobin trials in CKD: Methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant 2007; 22: 309-312
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 309-312
    • Levin, A.1
  • 5
    • 0030921662 scopus 로고    scopus 로고
    • NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997; 30[4 Suppl 3]:S192-S240
    • NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997; 30[4 Suppl 3]:S192-S240
  • 6
    • 0035228407 scopus 로고    scopus 로고
    • NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. POWER Study Group. Am J Kidney Dis 2001; 37 [1 Suppl 1]: S182-S238
    • NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. POWER Study Group. Am J Kidney Dis 2001; 37 [1 Suppl 1]: S182-S238
  • 7
    • 2942744923 scopus 로고    scopus 로고
    • POWER study group. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease
    • Provenzano R, Garcia-Mayol L, Suchinda P et al. POWER study group. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clin Nephrol 2000; 61: 392-405
    • (2000) Clin Nephrol , vol.61 , pp. 392-405
    • Provenzano, R.1    Garcia-Mayol, L.2    Suchinda, P.3
  • 8
    • 23144460027 scopus 로고    scopus 로고
    • PROMPT Study Group. Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: The PROMPT study
    • Provenzano R, Bhaduri S, Singh AK. PROMPT Study Group. Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: The PROMPT study. Clin Nephrol 2005; 64: 113-123
    • (2005) Clin Nephrol , vol.64 , pp. 113-123
    • Provenzano, R.1    Bhaduri, S.2    Singh, A.K.3
  • 9
    • 9144239992 scopus 로고    scopus 로고
    • Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial
    • Roger SD, McMahon LP, Clarkson A et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial. J Am Soc Nephrol 2004; 15: 148-156
    • (2004) J Am Soc Nephrol , vol.15 , pp. 148-156
    • Roger, S.D.1    McMahon, L.P.2    Clarkson, A.3
  • 10
    • 33745050664 scopus 로고    scopus 로고
    • Dosing patterns, hematologic outcomes and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia
    • Papatheofanis FJ, McKenzie RS, Mody SH, Suruki RY, Piech CT. Dosing patterns, hematologic outcomes and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia. Curr Med Res Opin 2006; 22: 837-842
    • (2006) Curr Med Res Opin , vol.22 , pp. 837-842
    • Papatheofanis, F.J.1    McKenzie, R.S.2    Mody, S.H.3    Suruki, R.Y.4    Piech, C.T.5
  • 11
    • 23144442156 scopus 로고    scopus 로고
    • Extended epoetin alfa dosing in chronic kidney disease patients: A retrospective review
    • Epub 28 June
    • Germain M, Ram CV, Bhaduri S, Tang KL, Klausner M, Curzi M. Extended epoetin alfa dosing in chronic kidney disease patients: A retrospective review. Nephrol Dial Transplant 2005; 20: 2146-2152. Epub 28 June 2005
    • (2005) Nephrol Dial Transplant 2005 , vol.20 , pp. 2146-2152
    • Germain, M.1    Ram, C.V.2    Bhaduri, S.3    Tang, K.L.4    Klausner, M.5    Curzi, M.6
  • 12
    • 34547844636 scopus 로고    scopus 로고
    • Ortho Biotech. Clinical Study Report. http://download.veritasmedicine.com/PDF/CR000588_CSR.pdf
    • Ortho Biotech. Clinical Study Report. http://download.veritasmedicine.com/PDF/CR000588_CSR.pdf
  • 13
    • 33846669860 scopus 로고    scopus 로고
    • Mortality and target haemoglobin concentrations in anemia patients with chronic kidney disease treated with erythropoietin: A meta-analysis
    • Phrommintikul A, Haas SJ, Elsik M, Klum H. Mortality and target haemoglobin concentrations in anemia patients with chronic kidney disease treated with erythropoietin: A meta-analysis. Lancet 2007; 369: 381-388
    • (2007) Lancet , vol.369 , pp. 381-388
    • Phrommintikul, A.1    Haas, S.J.2    Elsik, M.3    Klum, H.4
  • 15
    • 0027934302 scopus 로고
    • Interim analysis: The alpha spending function approach
    • discussion 1353-1356
    • DeMets DL, Lan KK. Interim analysis: The alpha spending function approach. Stat Med 1994; 13: 1341-1352; discussion 1353-1356
    • (1994) Stat Med , vol.13 , pp. 1341-1352
    • DeMets, D.L.1    Lan, K.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.